Page last updated: 2024-11-09

rubeanic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rubeanic acid: indicator for copper, cobalt, & nickel; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2777982
CHEMBL ID3184806
SCHEMBL ID259606
SCHEMBL ID23782617
MeSH IDM0047467

Synonyms (58)

Synonym
c2h4n2s2
usaf ek-4394
usaf b-43
dithioxamide
ethanedithioamide
oxamide, dithio-
oxaldiimidic acid, dithio-
usaf mk-6
hydrorubeanic acid
RVK ,
rubeane
dithiooxamide
nsc-1893
rubean
wln: suyzyzus
nsc1893
rubeanic acid
79-40-3
ethanebis(thioamide)
nsc 1893
hsdb 5230
oxalic acid, dithiono-, diamide
einecs 201-203-9
dithiooxamide, 97%
D0957
AKOS000121555
A839674
NCGC00248827-01
dtxcid10546
NCGC00258321-01
cas-79-40-3
tox21_200767
dtxsid3020546 ,
unii-he28t8z08d
he28t8z08d ,
FT-0625371
SCHEMBL259606
rubeanic acid [mi]
1,2-ethanedisulfenamide
W-203815
dithiooxalic acid diamide
dithio oxamide
CHEMBL3184806
mfcd00004941
dithiooxamide, for spectrophotometric det. of cu, os, bi, co, cu, fe, ni, os, pt, ru, >=98.5%
dithiooxamide, p.a., 98.0%
Z56347000
rubeanicacid
F0001-2077
Q5283666
methyl6-(1-boc-piperidin-4-yloxy)indole-2-carboxylate
EN300-16583
STL185575
D78448
SY049427
AS-57364
CS-W011204
SCHEMBL23782617
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency48.96620.000214.376460.0339AID720691
retinoid X nuclear receptor alphaHomo sapiens (human)Potency17.37390.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency59.08500.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401; AID1259403
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency34.08110.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (46.88)18.7374
1990's3 (9.38)18.2507
2000's6 (18.75)29.6817
2010's6 (18.75)24.3611
2020's2 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.44 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index51.72 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]